Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors.

[1]  R. Mammadov,et al.  Is It Possible to Predict Sepsis, the Most Serious Complication in Prostate Biopsy? , 2009, Urologia Internationalis.

[2]  A. Erol,et al.  Prospective assessment of the efficacy of single dose versus traditional 3‐day antimicrobial prophylaxis in 12‐core transrectal prostate biopsy , 2008, International journal of urology : official journal of the Japanese Urological Association.

[3]  Chao-yuan Huang,et al.  Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in taiwan. , 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  R. Schmid,et al.  Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray. , 2007, International journal of medical microbiology : IJMM.

[5]  M. Grabe,et al.  Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. , 2006, European urology.

[6]  C. Padovani,et al.  Complications and risk factors in transrectal ultrasound-guided prostate biopsies. , 2006, Sao Paulo medical journal = Revista paulista de medicina.

[7]  M. Yasuda,et al.  Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy , 2005, World Journal of Urology.

[8]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[9]  F. Saad,et al.  A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. , 2004, The Canadian journal of urology.

[10]  Georg Bartsch,et al.  Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. , 2004, The Journal of urology.

[11]  S. Jeon,et al.  Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. , 2003, Urology.

[12]  P. Pietrzak,et al.  Morbidity of transrectal ultrasonography‐guided prostate biopsies in patients after the continued use of low‐dose aspirin , 2003, BJU international.

[13]  M. Soloway,et al.  The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. , 2002, The Journal of urology.

[14]  C. Abbou,et al.  EAU guidelines on prostate cancer. , 2009, European urology.

[15]  H. Korman,et al.  Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? , 2002, The Journal of urology.

[16]  A. Zlotta,et al.  Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. , 2001, The Journal of urology.

[17]  E. Belgrano,et al.  [Transrectal ultrasound-guided biopsy of the prostate]. , 2000, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[18]  M. Terris,et al.  Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. , 2000, The Journal of urology.

[19]  M. Aron,et al.  Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study , 2000, BJU international.

[20]  J. Wolf,et al.  Review of antibiotic prophylaxis recommendations for office-based urologic procedures. , 1999, Techniques in urology.

[21]  K C Shandera,et al.  Variability in patient preparation for prostate biopsy among American urologists. , 1998, Urology.

[22]  G. E. Deshon,et al.  Efficacy of one dose fluoroquinolone before prostate biopsy. , 1998, Urology.

[23]  D. Kapoor,et al.  Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. , 1998, Urology.

[24]  F. Schröder,et al.  Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. , 1997, Urology.

[25]  E. Varenhorst,et al.  Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. , 1997, British journal of urology.

[26]  J. Hugosson,et al.  Infection after transrectal core biopsies of the prostate--risk factors and antibiotic prophylaxis. , 1996, British journal of urology.

[27]  M A Gerber,et al.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association. , 1990, JAMA.

[28]  W. Cooner,et al.  Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.

[29]  K. Naber.  Use of quinolones in urinary tract infections and prostatitis. , 1989, Reviews of infectious diseases.

[30]  E. Crawford,et al.  Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. , 1982, The Journal of urology.

[31]  A. Bolger,et al.  Prevention of bacterial endocarditis. , 1983, Medical times.